You searched for "elective"

1998 results found

Preview: UKISCRS 48th Annual Congress 2024

One of the biggest UKISCRS events is upon us, and we’ll all by making our way down there in the next several weeks or so. Not only is it the 75th anniversary of the IOL, but it is also the...

Considerations in the management of retinal disorders

Vision research presentations and publications explore practice considerations in the management of AMD and diabetic retinopathy. Over the past two decades in Europe there has been a decreasing prevalence of age-related macular degeneration (AMD) and an improvement in visual acuity...

2018 update on intravitreal injections

In this review article the authors have highlighted the standardised and structured approach to intravitreal injections (IVI) by examining the recent evidence-based literature. IVI is the most commonly performed procedure worldwide with low potential risk of endophthalmitis. IOP spikes are...

New research shows the unhealthy state of access to medicine and medical devices for blind patients

Blind and partially sighted people could become ill from medicines and medical devices, because they are not being listened to when it comes to designing, prescribing and administering treatments. The Safety Gap’ report commissioned by the Patient Safety Commissioner, Prof...

Aqueous humour cytokine levels in PCV and nAMD

This study looks into the possible roles of various cytokines or growth factors in the pathogenesis of exudative age-related macular degeneration (AMD) by comparing aqueous levels of 14 cytokines between eyes with polypoidal choroidal vasculopathy (PCV) and those with neovascular...

Fenofibrate and diabetic retinopathy

Fenofibrate is an agonist of peroxisome proliferator-activated receptor-alpha (PPARα) which is used as a lipid-lowering agent. By reducing blood lipid levels, it can decrease retinal hard exudates which is beneficial in diabetic retinopathy (DR). FIELD and ACCORD studies show that...

Refined glaucoma referral practice offers prospect of improved capacity and expanded role for primary eye care professionals

Glaucoma is the most frequent cause of irreversible blindness worldwide and the second leading cause of blindness in the UK [1,2]. The global prevalence of glaucoma in 2010 was approximately 3.5% for people aged 40-80 years, according to Jonas et...

A look into the IOL space

Advances in the design and performance of intraocular lenses (IOLs) continue to be driven by demand for better outcomes, presbyopia correction and spectacle independence, alongside a better understanding of the dynamics of the crystalline lens, newer theories of accommodation and...

Manchester Royal Eye Hospital first in UK to use ultra-wide field OCT angiography machine in patient facing setting

Manchester Royal Eye Hospital announces it is the first in the UK to utilise the ultra-wide field OCT angiography machine, the Xephilio OCT-S1 from Canon, in a patient facing setting.

Hype or helpful: ChatGPT

It would have been hard to miss all the attention chatbots have received over the last few months. Whilst ChatGPT is easily the most well-known example of the large language models that have become so widespread of late, artificial intelligence...

New IGA research award

Applications open for new £50,000 glaucoma research Allied Healthcare professionals award The International Glaucoma Association (IGA) announces call for applications for new £50,000 Allied Healthcare professionals award for glaucoma research. The new award, which opened on 21 October 2019 and...

Fight for Sight continues to promote eye research

Eye research charity Fight for Sight has announced its latest project funding and its plans for continuing its efforts to advance eye research in the current global health crisis and beyond.